ADVERTISEMENTs

FedEx launches life science centre in Mumbai

The new facility will cater to healthcare customers' clinical trial storage and logistics needs in India and globally

The centre marks a significant advancement in the clinical trial supply chain both in India and worldwide / Image - X @FedExIndia

FedEx Express, a subsidiary of FedEx Corp., has launched its 'FedEx Life Science Center' in Mumbai. The new facility will cater to healthcare customers' clinical trial storage and logistics needs in India and globally, a statement from the firm said.

The new FedEx Life Science Center complies with the quality and regulatory standards of the healthcare industry. It boasts comprehensive temperature-controlled zones, including controlled ambient (15°C to 25°C), refrigerated (2°C to 8°C), and frozen (-20°C and Deep Frozen -80°C), ensuring the safe storage of sensitive medical products.

A centralized monitoring system maintains temperature and humidity integrity, while stringent security measures, including earthquake resistance standards, safeguard the facility. It is equipped with 24/7 alarm systems that guarantee immediate responses and interventions.

Gel packs and dry ice are used for secure packing, while a backup power generator ensures uninterrupted operations. Additional services include destroying returned investigational medicinal products (IMPs) and securing document storage with fire-safe walls.

Commenting on the facility, Nitin Navneet Tatiwala, vice president of FedEx Express, marketing, Middle East, India Sub-continent and Africa (MEISA) said, “With FedEx having deep expertise in handling critical clinical trial shipments, the launch of FedEx Life Science Center (LSC) will act as a one-stop shop for all clinical trial storage and distribution requirements of healthcare customers in India.”

“The new center is in addition to FedEx’s current LSCs in Japan, South Korea, Singapore, the USA, and the Netherlands – making it a global network of storage and distribution depots to support our healthcare and pharmaceutical customers,” Tatiwala said.

Comments

ADVERTISEMENT

 

 

 

ADVERTISEMENT

 

 

E Paper